Sodium–Glucose Cotransporter 2-Mediated Glucose Uptake Contributes to Glycogen Accumulation in Clear Cell Renal Cell Carcinoma: Implications for Clear Cell Morphology and Potential Therapeutic Relevance
Authors:
- Yujiro NagataYNYujiro Nagata
- Ikko TomisakiITIkko Tomisaki
- Takuo MatsukawaTMTakuo Matsukawa
- Nguyen Thu QuynhNguyen Thu Quynh
- Yuto TsubonumaYTYuto Tsubonuma
- Yoshihiro SugitaYSYoshihiro Sugita
- Aya NawataANAya Nawata
- Keiji KokubuKKKeiji Kokubu
- Ryoko BabaRBRyoko Baba
- Hiroyuki MorimotoHMHiroyuki Morimoto
- Kohei OgawaKOKohei Ogawa
- Koichiro WadaKWKoichiro Wada
Open Access
- 15 October 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9128
Abstract
Clear cell renal cell carcinoma (ccRCC) is characterized by loss of the functional von Hippel–Lindau (VHL) complex and distinctive clear cell morphology associated with intracellular glycogen and lipid accumulation. However, the mechanism underlying glycogen storage remains unclear. This study was conducted to investigate the relationship between SGLT2, a glucose transporter predominantly expressed in proximal tubular epithelial cells; the cell of origin of ccRCC; and clear cell morphology in ccRCC. Using the VHL-null ccRCC cell line KMRC-1, we investigated the effects of the SGLT2 inhibitor dapagliflozin, SGLT2 knockdown, and VHL overexpression on cellular morphology, intracellular glycogen accumulation, and glucose uptake. Immunohistochemical expression of SGLT2, glucose transporter 1, and VHL was evaluated in morphologically heterogeneous ccRCC specimens. Periodic acid–Schiff (PAS) and PAS with diastase staining, together with quantitative image analysis of PAS-stained cells, showed that dapagliflozin treatment, SGLT2 knockdown, and VHL restoration reduced cytoplasmic area and cytoplasmic PAS staining intensity in KMRC-1 cells. In the fluorescent glucose uptake assay, dapagliflozin significantly reduced the fluorescence signal (p < 0.05). In paired intratumoral analyses of six VHL-deficient ccRCC specimens, SGLT2 immunohistochemical scores were significantly higher in clear cell components than in eosinophilic components (p = 0.026), whereas GLUT1 scores did not differ significantly (p = 0.850). These findings suggest that SGLT2-mediated glucose uptake contributes to glycogen accumulation and the glycogen-rich clear cell morphology of VHL-deficient ccRCC. The potential therapeutic relevance of SGLT2 inhibition in ccRCC warrants further investigation.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP24K19662)
This publication has 51 references indexed in Scilit:
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 UpdateEuropean Urology, 2025
- Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targetsHeliyon, 2024
- Chromophobe renal cell carcinomaCancer Cell, 2023
- Epidemiology of Renal Cell Carcinoma: 2022 UpdateEuropean Urology, 2022
- The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular TumoursEuropean Urology, 2022
- Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx RenalCell, 2018
- An Integrated Metabolic Atlas of Clear Cell Renal Cell CarcinomaCancer Cell, 2016
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissuesHuman Pathology, 1997
- Comparative light and electron microscopic observations of the cytoplasmic matrix in renal carcinomasVirchows Archiv, 1966